Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02272179 · ClinicalTrials.gov registry record · Phase 1

Brief Intervention for Suicide Risk Reduction in High Risk Adolescents

A Phase 1 study, sponsored by University of Pittsburgh.

Completed
Registry status
Phase 1
Development phase
68
Enrollment target

NCT02272179 is a Phase 1 study that has completed, run by University of Pittsburgh. The registered enrollment target is 68 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02272179, a Phase 1 study, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
Phase 1
Development phase
68 participants
Enrollment target

Study Summary

Adolescent suicide is the 2nd leading cause of death in this age group. There are no validated treatments to decrease the risk of adolescent suicidal behavior, and there are especially no interventions to target the highest risk period for adolescent suicide and suicidal behavior, namely during the time of transition from inpatient to outpatient care. This purpose of this project was to develop a novel, brief intervention that can be delivered on an inpatient unit prior to the transition to outpatient care, and augment known factors to protect adolescents from suicidal behavior, and extend the impact of treatment by liaison with the outpatient therapist and the development of a personalized safety plan phone application. This treatment, ASAP, focuses on augmenting adherence to the components of ASAP and outpatient aftercare, development of a personalized Safety Plan, and Affect Protection, through helping the teen and family promote a positive mood, tolerate distress, engage in healthy emotion regulation and access social support.

Interventions

  • BEHAVIORAL Treatment as Usual
  • BEHAVIORAL As Safe As Possible
  • BEHAVIORAL Brite

Trial Details

FieldValue
Enrollment Target 68 participants
Start Date 2014-02
Est. Completion 2017-11
Phase Phase 1

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT02272179

The ClinicalTrials.gov registry entry for NCT02272179 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Treatment as Usual is the first listed.

NCT02272179 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02272179 about?

NCT02272179 is a clinical study titled "Brief Intervention for Suicide Risk Reduction in High Risk Adolescents". Adolescent suicide is the 2nd leading cause of death in this age group. There are no validated treatments to decrease the risk of adolescent suicidal behavior, and there are especially no interventions to target the highest risk period for adolescent suicide and suicidal behavior, namely during the ...

What is the current status of trial NCT02272179?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 68 participants. The study started on 2014-02. Estimated completion is 2017-11.

What interventions are being tested in trial NCT02272179?

The interventions under investigation include: Treatment as Usual (BEHAVIORAL), As Safe As Possible (BEHAVIORAL), Brite (BEHAVIORAL).

Who is sponsoring clinical trial NCT02272179?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.